ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT

Aim. To evaluate parameters of arterial stiffness by non-invasive arteriography in patients with moderate/high cardiovascular risk receiving lisinopril and simvastatin.Material and methods. 20 patients (aged 50-55 y.o.) with arterial hypertension of the 1st degree and dislipidemia are included in th...

Full description

Saved in:
Bibliographic Details
Main Authors: V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/656
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227874117091328
author V. N. Isakova
O. G. Garbuzova
E. V. Klinkova
E. V. Bandurko
author_facet V. N. Isakova
O. G. Garbuzova
E. V. Klinkova
E. V. Bandurko
author_sort V. N. Isakova
collection DOAJ
description Aim. To evaluate parameters of arterial stiffness by non-invasive arteriography in patients with moderate/high cardiovascular risk receiving lisinopril and simvastatin.Material and methods. 20 patients (aged 50-55 y.o.) with arterial hypertension of the 1st degree and dislipidemia are included in the study. All patients had pulse wave velocity (PWV) ≥ 10 m/s and/or the corrected index of pulse wave augmentation (AI × 80) ≥ -10% according to non-invasive arteriography data; and moderate-high cardiovascular risk (≥ 3%). Patients received therapy with lisinopril and simvastatin. Blood pressure (BP) levels and lipid profiles were assessed before therapy and in 1, 2, 6 and 12 month of the observation. Non-invasive arteriography was performed before therapy and in 2, 6 and 12 months later.Results. BP target levels were reached within 1 month of treatment as well as improvement of lipid profile was reached within 2 months in majority of the patients. Reference PWV and AI were reached in 85,7% of patients within one year of treatment.Conclusion. Arterial stiffness parameters help to evaluate cardiovascular risk changes accurately as the results of treatment.
format Article
id doaj-art-77952a2c2ceb4cfa88167c225f30466e
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2016-01-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-77952a2c2ceb4cfa88167c225f30466e2025-08-23T10:00:22ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0153141810.20996/1819-6446-2009-5-3-14-18655ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENTV. N. Isakova0O. G. Garbuzova1E. V. Klinkova2E. V. Bandurko3The Medical Centre “Prima Medica”, The Far-Eastern State Medical UniversityThe Medical Centre “Prima Medica”, The Far-Eastern State Medical UniversityThe Medical Centre “Prima Medica”The Medical Centre “Prima Medica”Aim. To evaluate parameters of arterial stiffness by non-invasive arteriography in patients with moderate/high cardiovascular risk receiving lisinopril and simvastatin.Material and methods. 20 patients (aged 50-55 y.o.) with arterial hypertension of the 1st degree and dislipidemia are included in the study. All patients had pulse wave velocity (PWV) ≥ 10 m/s and/or the corrected index of pulse wave augmentation (AI × 80) ≥ -10% according to non-invasive arteriography data; and moderate-high cardiovascular risk (≥ 3%). Patients received therapy with lisinopril and simvastatin. Blood pressure (BP) levels and lipid profiles were assessed before therapy and in 1, 2, 6 and 12 month of the observation. Non-invasive arteriography was performed before therapy and in 2, 6 and 12 months later.Results. BP target levels were reached within 1 month of treatment as well as improvement of lipid profile was reached within 2 months in majority of the patients. Reference PWV and AI were reached in 85,7% of patients within one year of treatment.Conclusion. Arterial stiffness parameters help to evaluate cardiovascular risk changes accurately as the results of treatment.https://www.rpcardio.online/jour/article/view/656non-invasive arteriographypulse wave velocitylisinoprilsimvastatin
spellingShingle V. N. Isakova
O. G. Garbuzova
E. V. Klinkova
E. V. Bandurko
ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT
Рациональная фармакотерапия в кардиологии
non-invasive arteriography
pulse wave velocity
lisinopril
simvastatin
title ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT
title_full ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT
title_fullStr ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT
title_full_unstemmed ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT
title_short ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT
title_sort arterial stiffness parameters in patients with moderate high cardiovascular risk during lisinopril and simvastatin treatment
topic non-invasive arteriography
pulse wave velocity
lisinopril
simvastatin
url https://www.rpcardio.online/jour/article/view/656
work_keys_str_mv AT vnisakova arterialstiffnessparametersinpatientswithmoderatehighcardiovascularriskduringlisinoprilandsimvastatintreatment
AT oggarbuzova arterialstiffnessparametersinpatientswithmoderatehighcardiovascularriskduringlisinoprilandsimvastatintreatment
AT evklinkova arterialstiffnessparametersinpatientswithmoderatehighcardiovascularriskduringlisinoprilandsimvastatintreatment
AT evbandurko arterialstiffnessparametersinpatientswithmoderatehighcardiovascularriskduringlisinoprilandsimvastatintreatment